Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.4, 2005-04, pp. : 511-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telbivudine for Chronic Hepatitis B. A Review

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 4, 2008-10 ,pp. : 245-248

Bentham Science Publishers

Access to resources Recommend Favorite

Telbivudine for the treatment of hepatitis B disease

By Tsunoda Shirley M Hassanein Tarek

Future Virology, Vol. 3, Iss. 6, 2008-11 ,pp. : 517-527

Future Medicine

Access to resources Recommend Favorite

Telbivudine myopathy in a patient with chronic hepatitis B

By Wang Min

International Journal of Clinical Pharmacy, Vol. 34, Iss. 3, 2012-06 ,pp. : 422-425

Springer Publishing Company

Access to resources Recommend Favorite

Telbivudine for chronic hepatitis B: the GLOBE trial

By Yuen Man-Fung Lai Ching-Lung

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 317-323

Future Medicine

Access to resources Recommend Favorite

Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses

By Hann Hie-Won

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2243-2249

Informa Healthcare

Access to resources Recommend Favorite